These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8734346)

  • 1. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).
    Baretton GB; Vogt M; Müller C; Diebold J; Schneiderbanger K; Schmidt M; Löhrs U
    Scand J Gastroenterol; 1996 May; 31(5):481-9. PubMed ID: 8734346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-expression and chromosome 17-copy number in colorectal adenomas.
    Baretton G; Vogt M; Diebold J; Blasenbreu S; Schneiderbanger K; Lohrs U
    Oncol Rep; 1996 Mar; 3(2):357-63. PubMed ID: 21594373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas.
    Clausen OP; Lothe RA; Børresen-Dale AL; De Angelis P; Chen Y; Rognum TO; Meling GI
    Diagn Mol Pathol; 1998 Aug; 7(4):215-23. PubMed ID: 9917132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
    Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
    J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
    Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
    Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
    Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
    Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
    Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
    J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and aneusomy of chromosomes 4, 10 and 12 in colorectal carcinomas.
    Beyer K; Altendorf-Hofmann A; Chen Y; Bickel K; Petersen I
    Pathol Res Pract; 2015 Sep; 211(9):646-51. PubMed ID: 26122820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
    Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.
    Meling GI; Lothe RA; Børresen AL; Graue C; Hauge S; Clausen OP; Rognum TO
    Br J Cancer; 1993 Jan; 67(1):93-8. PubMed ID: 8427784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas.
    De Angelis PM; Stokke T; Beigi M; Flatberg G; Enger M; Haug K; Aass HC; Schjølberg A; Andresen PA; Ariansen S; Bø AS; Mjåland O; Clausen OP
    Int J Cancer; 2007 Jun; 120(12):2734-8. PubMed ID: 17354231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between DNA content and p53 deletion in colorectal cancer.
    Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
    Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.